Bajrang Dal holds arms training camp in Ayodhya, other sensitive areas

Mangaluru, Apr 14: Karnataka Chief Minister B S Yediyurappa today wished the people of Tulu Nad a Happy Bishu in Tulu language.

Yediyurappa took to Twitter on Tuesday and wrote in Tulu, 'Happy Vishu to everyone! A new year brings new hope and new energy. May the coming year bring good health and well-being in everyone’s lives.'

Bishu – the traditional New Year for the Hindus in Dakshina Kannada and Udupi, which begins from Tuesday is believed to signal the arrival of good luck and fortune for the coming year.

Bhatkal, May 8: In a shocking development 12 new coronavius positive cases were detected in Bhatkal town of Uttara Kannada district in a single day. 

Around 20 days ago an 18-year-old girl in Bhatkal was tested positive for the covid-19. The source of this infection was the First Neuro hospital located at Padil in Mangaluru where a covid-19 patient from Bantwal had undergone treatment. 

Now, the Bhatkal girl’s family members and neighbours also have tested positive for the deadly virus. Madeena Colony, Usmainya Colony, Nawayath Colony, Tengungundi Cross, Hindu Colony, Kukti Nagar, Jali Cross and Azad Nagar are sealed down by officials after the confirmation of new cases. 

Those infected include a 5-month-old baby, elderly people aged 60, 75, 83 and children aged 3, 11 and 12 years. 

Meanwhile, Kumata-Honnavar MLA Dinakar K Shetty has written to Uttara Kannada DC urging the complete seal down of Bhatkal taluk.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.